Award Recognizes Entrepreneurial Excellence in Health and Life Sciences
Category
SUNNYVALE, Calif., June 17 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today
that Euan Thomson, Ph.D., the company's president and CEO, received the Ernst
& Young Entrepreneur Of The Year(R) 2009 Award in the Health and Life Sciences
category in Northern California. According to Ernst & Young LLP, the award
recognizes outstanding entrepreneurs who are building and leading dynamic,
growing businesses. Euan Thomson was selected by an independent panel of
judges, and the award was presented at a gala event at The San Jose Fairmont
on June 13, 2009.
"Being named an Entrepreneur of the Year for Northern California is a real
honor that I share with all of Accuray's employees, both past and present, as
a tribute to their hard work and dedication over the years," said Euan
Thomson, Ph.D., the company's president and CEO of Accuray. "I am also
grateful to the doctors and patients who have helped to build the CyberKnife
program and made it the success that it is today."
The Ernst & Young Entrepreneur Of The Year awards celebrate their 23rd
anniversary this year. The program honors entrepreneurs who have demonstrated
exceptionality in such areas as innovation, financial performance and personal
commitment to their businesses and communities.
"We are proud to recognize the achievements of Euan Thomson," said Ernie
Cortes, Ernst & Young LLP Entrepreneur Of The Year Program Director for
Northern California. "Award recipients of the Entrepreneur Of The Year award
build leading businesses and contribute significantly to the strength of our
region's economy. Their success helps our area grow stronger."
As a Northern California award recipient, Euan Thomson is now eligible for
consideration for the Ernst & Young LLP Entrepreneur Of The Year 2009 national
program. Award recipients in several national categories, as well as the
overall national Ernst & Young Entrepreneur Of The Year award recipient, will
be announced at the annual awards gala in Palm Springs, California on November
14, 2009. The awards are the culminating event of the Ernst & Young Strategic
Growth Forum, the nation's most prestigious gathering of high-growth,
market-leading companies.
About Ernst & Young's Entrepreneur Of The Year(R) Awards Program
Ernst & Young's Entrepreneur Of The Year(R) Award is the world's most
prestigious business award for entrepreneurs. The award makes a difference
through the way it encourages entrepreneurial activity among those with
potential and recognizes the contribution of people who inspire others with
their vision, leadership and achievement. As the first and only truly global
award of its kind, the Ernst & Young Entrepreneur Of The Year(R) award
celebrates those who are building and leading successful, growing and dynamic
businesses, recognizing them through regional, national and global awards
programs in more than 135 cities in 50 countries.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 60,000 patients
worldwide and currently more than 164 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please visit
www.accuray.com.
Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Euan Thomson, Ph.D.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
SOURCE Accuray Incorporated
06/17/2009
CONTACT: Stephanie Tomei, Senior Manager, Public Relations, of Accuray
Inc., +1-408-789-4234, stomei@accuray.com; or Brianne Donahue of Schwartz
Communications, +1-415-817-2545, bdonahue@schwartz-pr.com, for Accuray Inc.
Web Site: http://www.accuray.com
